BRIGHT MINDS BIOSCIENCES INC. 13D

Ian McDonald holds about 13.6% of Bright Minds Biosciences Inc. and, while reserving the right to trade his position, currently disclaims any activist or control-seeking intentions.

On July 2, 2026, Ian McDonald, President, CEO and Director of Bright Minds Biosciences Inc., reported beneficial ownership of 1,398,290 common shares (including prior derivative securities), representing approximately 13.6% of the company, reflecting a reduced percentage over time driven primarily by issuer share distributions rather than sales by him; he states largely passive intentions, reserving the right to buy or sell shares opportunistically but with no current plans for board, strategic, or control-related actions.

Filing Facts

CIK

1827401

Ticker

DRUG

Form

13D

Source Type

sec

Accession

0001062993-26-003506

Alert Tier

6